Company Profile:
NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY is a factory.
Company Introduction:
NAVETCO National Veterinary Joint Stock Company is a leading Vietnamese enterprise specializing in the research, development, and manufacturing of veterinary vaccines, biological products, and pharmaceuticals for animal health. Established in 1955, NAVETCO has a long-standing history and plays a crucial role in the veterinary industry of Vietnam and the region.
Key aspects of NAVETCO:
* Manufacturer: The company operates extensive production facilities dedicated to producing a wide range of veterinary products, including live and inactivated vaccines, biological diagnostic kits, and various pharmaceutical formulations.
* Research and Development: NAVETCO places a strong emphasis on scientific research and technological innovation, constantly developing new products and improving existing ones to address evolving animal health challenges.
* Product Portfolio: Their product line covers a broad spectrum of animal diseases, catering to poultry, swine, cattle, aquaculture, and other livestock.
* Quality Standards: NAVETCO adheres to international quality standards, including Good Manufacturing Practice (GMP-WHO), ensuring the safety, efficacy, and quality of its products.
* Market Reach: While primarily serving the domestic Vietnamese market, NAVETCO also exports its products to several countries in Southeast Asia and beyond, contributing to global animal health.
Enterprise Products
Here are some of the products that NAVETCO NATIONAL VETERINARY JOINT-STOCK COMPANY (Vietnam) produces or sells:
* **Veterinary drugs:**
* Antibiotics
* Antiparasitics
* Antipyretics
* Analgesics
* Anti-inflammatory drugs
* **Vaccines:**
* For poultry
* For livestock
* For aquaculture
* **Feed supplements:**
* Vitamins
* Minerals
* Amino acids
* Probiotics
* **Disinfectants:**
* For animal housing
* For equipment
* **Diagnostic products:**
* Test kits
I will try to provide more specific details about product names and applications if you have further questions.